Apparatus and method for arrhythmia detection by variations in the transcardiac impedance between defibrillation patches

• US 5,179,946 A
• Filed: 11/26/1990
• Issued: 01/19/1993
• Est. Priority Date: 12/28/1989
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories)
• Inventors: Weiss, Steven M.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US07/617,987
• Time in Patent Office: 785 Days
• Field of Search: 128/419 D, 128/734, 128/723, 128/670, 128/671, 128/419 PG
• US Class Current: 607/4
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable device for the treatment of malfunctions of a patient'"'"'s heart is disclosed. The device employs defibrillation patch electrodes positioned on the outer surface of the heart generally outwardly of the left and right ventricles of the heart, in conjunction with a non-polarizing sub-threshold constant current or constant voltage signal and appropriate electronic signal sensing and processing circuitry, to determine changes in variations of the transcardiac impedance of a patient'"'"'s heart, such changes being representative of corresponding changes in the level of haemodynamic compromise of the heart. Bradycardia support pacing therapy, antitachycardia pacing therapy, cardioversion therapy and defibrillation therapy, or no therapy, are selectively initiated by the device, depending on the level of haemodynamic compromise determined to be extent by the device. Conventional electrical function sensing may be employed in conjunction with the sensed changes in variations of the transcardiac impedance to control the device. Corresponding methods of treating malfunctions of a patient'"'"'s heart are also disclosed.

Claims

1. Apparatus for measuring the haemodynamic condition of a patient'"'"'s heart, comprising:

at least two cardioversion/defibrillation electrodes adapted to be positioned on the outer surface of the ventricles of the patient'"'"'s heart generally across the short axis of said ventricles whereby at least the major portion of one of said electrodes is positioned on the left ventricular free wall;

means coupled to said electrodes for sensing normal variations in the transcardiac impedance between said electrodes and determining the magnitude thereof;

means for determining changes in the magnitude of the pulsations of said normal variations of said transcardiac impedance; and

means responsive to said pulsation magnitude changes in normal variations of said transcardiac impedance for providing signals indicative of changes in the haemodynamic condition of the patient'"'"'s heart.

2. Apparatus according to claim 1, further including heart malfunction treatment means responsive to said signals for selectively providing or not providing therapy to the patient'"'"'s heart based on levels of haemodynamic compromise represented by said signals.

3. Apparatus according to claim 1, further including heart malfunction treatment means responsive to said signals for selectively providing one of a plurality of different therapies to the patient'"'"'s heart, and wherein the therapy selected corresponds to a level of haemodynamic compromise represented by said signals.

4. Apparatus according to claim 2, wherein said signals comprise first signals representative of haemodynamic function, wherein said apparatus is implantable in the patient and further includes at least two additional electrodes adapted to be positioned within the patient'"'"'s heart and means coupled to said additional electrodes for sensing an electrical function in the patient'"'"'s heart and providing second signals representative of said electrical function, and wherein said heart malfunction treatment means is responsive both to said first signals and to said second signals in selectively providing or not providing therapy to the patient'"'"'s heart.

5. Apparatus according to claim 3, wherein said signals comprise first signals representative of haemodynamic function, wherein said apparatus is implantable in the patient and further includes at least two additional electrodes adapted to be positioned within the patient'"'"'s heart and means coupled to said additional electrodes for sensing an electrical function in the patient'"'"'s heart and providing second signals representative of said electrical function, and wherein said heart malfunction treatment means is responsive both to said first signals and to said second signals in selectively providing one of said plurality of different therapies to the patient'"'"'s heart.

6. Apparatus according to claim 4, wherein said at least two outer surface electrodes comprise defibrillation patches, and wherein said heart malfunction treatment means includes means for providing at least bradycardia support pacing therapy, antitachycardia pacing therapy and cardioversion/defibrillation therapy.

7. Apparatus according to claim 5, wherein said at least two outer surface electrodes comprise defibrillation patches, and wherein said heart malfunction treatment means includes means for providing at least bradycardia support pacing therapy, antitachycardia pacing therapy and cardioversion/defibrillation therapy.

8. Apparatus according to any one of claims 1-7, wherein said means coupled to said at least two outer surface electrodes for sensing normal variations in the transcardiac impedance between said electrodes includes a driver signal source circuit means for generating a non-polarization sub-threshold signal that is applied to said electrodes, and a sensed signal circuit means for sensing different amplitudes of modulation in said sensed signal due to variations in transcardiac impedance between said electrodes.

9. Apparatus according to claim 8, wherein said driver signal source circuit means generates a constant current output signal that is coupled to said first and second electrodes.

10. Apparatus according to claim 8, wherein said driver signal source circuit means generates a constant voltage output signal that is coupled to said at least two outer surface electrodes.

11. Apparatus according to claim 8, further including defibrillation protection means connected between said means for sensing normal variations in said transcardiac impedance and said at least two outer surface electrodes for selectively decoupling said means from said electrodes during any application of defibrillation therapy to the patient'"'"'s heart.

12. Apparatus according to claim 7, wherein said means coupled to said at least two outer surface electrodes for sensing normal variations in the transcardiac impedance between said electrodes includes a driver signal source circuit means for generating a nonpolarizing sub-threshold signal that is applied to said electrodes, and a sensed signal circuit means for sensing different amplitudes of modulation in said sensed signal due to variations in transcardiac impedance between said electrodes, said sensed signal circuit means further including demodulating means for both demodulating said sensed signal and filtering out any DC offset in said signal, and discriminator means for determining the amplitude of each cycle of said demodulated signal and either averaging the amplitudes of a predetermined number of such cycles or detecting cycle amplitudes that cross predetermined threshold boundaries.

13. Apparatus according to claim 7, wherein said means coupled to said at least two outer surface electrodes for sensing normal variations in the transcardiac impedance between said, electrodes includes a driver signal source circuit means for generating a nonpolarizing sub-threshold signal that is applied to said electrodes, and a sensed signal circuit means for sensing different amplitudes of modulation in said sensed signal due to variations in transcardiac impedance between said electrodes, said sensed signal circuit means further including demodulating means for both demodulating said sensed signal and filtering out any DC offset in said signal, and integration means coupled to said demodulating means for integrating said demodulated signal, whereby said integrated signal represents electrical energy and changes in magnitude of such electrical energy represent changes in the level of haemodynamic compromise.

14. Apparatus according to claim 12, wherein said means for providing signals corresponding to changes in the haemodynamic condition of the patient'"'"'s heart includes a digital microprocessor and an external memory coupled thereto, said external memory including a plurality of windows stored therein each of which corresponds to a different heart malfunction, treatment therapy, wherein said sensed signal circuit means includes analog to digital converter means coupled to both said discriminator means and said microprocessor for receiving output analog signals from said discriminator means, converting said analog signals to digital signals and passing said digital signals on to said microprocessor, and wherein said microprocessor maps said digital signals against said windows to determine the appropriate therapy, if any, to be delivered to the patient'"'"'s heart.

15. Apparatus according to claim 13, wherein said means for providing signals corresponding to changes in the haemodynamic condition of the patient'"'"'s heart includes a digital microprocessor and an external memory coupled thereto, said external memory including a plurality of windows stored therein each of which corresponds to a different heart malfunction treatment therapy, wherein said sensed signal circuit means includes analog to digital converter means coupled to both said integrator means and said microprocessor for receiving output analog signals from said integrator means, converting said analog signals to digital signals and passing said digital signals on to said microprocessor, and wherein said microprocessor maps said digital signals against said windows to determine the appropriate therapy, if any, to be delivered to the patient'"'"'s heart.

16. A method of measuring the haemodynamic condition of a patient'"'"'s heart, comprising:

positioning at least two cardioversion/defibrillation electrodes on the outer surface of the ventricles of the patient'"'"'s heart generally across the short axis of said ventricles whereby at least the major portion one of said electrodes is positioned on the left ventricular free wall;

sensing normal variations in the transcardiac impedance between said electrodes and determining the magnitude thereof;

determining changes in the magnitude of pulsations of said normal variations of said transcardiac impedance; and

,

providing signals indicative of changes in the haemodynamic condition of the patient'"'"'s heart responsive to said pulsation magnitude changes in normal variations of said transcardiac impedance.

17. A method according to claim 16, further including the step of selectively providing or not providing therapy to the patient'"'"'s heart based on the levels of haemodynamic compromise represented by said signals.

18. A method according to claim 16, further including the step of selectively providing one of a plurality of therapies to the patient'"'"'s heart, and wherein the therapy selected corresponds to a predetermined level of haemodynamic compromise represented by said signals.

19. A method according to claim 17, wherein said signals comprise first signals representative of haemodynamic function, and further including the steps of positioning at least two additional electrodes within the patient'"'"'s heart, sensing an electrical function in the patient'"'"'s heart, and providing second signals representative of said electrical function, and wherein said step of selectively providing or not providing therapy to the patient'"'"'s heart is based both on the level of haemodynamic compromise represented by said first signals and on the state of the electrical function represented by said second signals.

20. A method according to claim 18 wherein said signals comprise first signals representative of haemodynamic function, wherein said plurality of different therapies include at least bradycardia support pacing therapy, antitachycardia pacing therapy and defibrillation therapy, and further including the steps of positioning at least two additional electrodes within the patient'"'"'s heart, sensing an electrical function in the patient'"'"'s heart, and providing second signals representative of said electrical function, and wherein said step of selectively providing one of said plurality of different therapies to the patient'"'"'s heart is based both on the level of haemodynamic compromise represented by said first signals and on the state of the electrical function represented by said second signals.

21. A method according to any one of claims 16-20, wherein said step of sensing normal variations in the transcardiac impedance between said electrodes includes the further steps of generating a non polarizing sub-threshold constant current signal, applying said signal to said first and second electrodes and sensing different amplitudes of modulation in said signal due to variations in transcardiac impedance between said electrodes.

22. A method according to any one of claims 16-20, wherein said step of sensing normal variations in the transcardiac impedance between said electrodes includes the further steps of generating a non-polarizing sub-threshold constant voltage signal, applying said signal to said at least two outer surface electrodes, and sensing different amplitudes of modulation in said signal due to variations in transcardiac impedance between said electrodes.

23. A method according to claim 21, including the further steps of demodulating said sensed signal, and filtering out any DC offset in said signal.

24. A method according to claim 23, including the further step of determining the amplitude of each cycle of said demodulated signal.

25. A method according to claim 23, including the further step of integrating said demodulated signal.

26. A method according to claim 24, including the further step of averaging the amplitudes of a predetermined number of said cycles.

27. A method according to claim 24, including the further step of detecting cycle amplitudes that cross predetermined threshold boundaries.

28. A method according to claim 22, including the further steps of demodulating said sensed signal, and filtering out any DC offset in said signal.

29. A method according to claim 28, including the further step of determining the amplitude of each cycle of said demodulated signal.

30. A method according to claim 28, including the further step of integrating said demodulated signal.

31. A method according to claim 29, including the further step of averaging the amplitudes of a predetermined number of said cycles.

32. A method according to claim 29, including the further step of detecting cycle amplitudes that cross predetermined threshold boundaries.